Free shipping on all orders over $ 500

Mavacamten (MYK-461)

Cat. No. M10262

All AbMole products are for research use only, cannot be used for human consumption.

Mavacamten (MYK-461) Structure
Synonym:

SAR-439152; MYK-461

Size Price Availability Quantity
1mg USD 50  USD50 In stock
5mg USD 90  USD90 In stock
10mg USD 140  USD140 In stock
25mg USD 240  USD240 In stock
50mg USD 340  USD340 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Mavacamten, also known as SAR-439152 and MYK-461, is a first-in-class myosin inhibitor potentially for the treatment of hypertrophic cardiomyopathy. Mavacamten has IC50 values of 490, 711 nM for bovine cardiac and human cardiac, respectively. Mavacamten (SAR-439152) reduces contractility by decreasing the adenosine triphosphatase activity of the cardiac myosin heavy chain. MYK-461 reduces cardiac contractility, prevents left ventricular hypertrophy, and reverses pathologic remodeling. In cats, it relieves left ventricular outflow tract obstruction.

Chemical Information
Molecular Weight 273.33
Formula C15H19N3O2
CAS Number 1642288-47-8
Solubility (25°C) DMSO 65 mg/mL
Storage -20°C, sealed
References

[1] Raja F Kawas, et al. J Biol Chem. A small-molecule modulator of cardiac myosin acts on multiple stages of the myosin chemomechanical cycle

[2] Joshua A Stern, et al. PLoS One. A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic Cardiomyopathy

[3] Eric M Green, et al. Science. A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice

Related Myosin Products
Omecamtiv mecarbil

Omecamtiv Mecarbil is a First-In-Class selective small molecule cardiac myosin activator that directly targets the contractile machinery of the heart, binding and increasing the number of cardiac myosin head regions interacting with actin during contraction.

(-)-Blebbistatin

(-)-Blebbistatin is a cell-permeable inhibitor for non muscle myosin II ATPase with IC50 of ~2 μM, does not inhibit myosin light chain kinase, inhibits contraction of the cleavage furrow without disrupting mitosis or contractile ring assembly. *The compound is unstable in solutions, freshly prepared is recommended

2,3-Butanedione monoxime

2,3-Butanedione Monoxime (BDM) is a myosin ATPASE inhibitor. 2,3-Butanedione Monoxime is a skeletal and cardiac muscle contraction inhibitor. 2,3-Butanedione monoxime induces sarcoplasmic reticulum Ca2+ release.

TR100

TR100 is a specific anti-tropomyosin agent that preferentially disrupts the actin cytoskeleton of tumor cells. TR100 selectively disrupts Tm5NM1/2 containing actin filaments.

Blebbistain

(±)-Blebbistatin (BLEB) is a small cell permeable selective myosin II inhibitor which potently relaxed normal detrusor smooth muscle.

  Catalog
Abmole Inhibitor Catalog




Keywords: Mavacamten (MYK-461), SAR-439152; MYK-461 supplier, Myosin, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.